Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Advanced Solid Tumors 69Advanced Solid Tumor 58Solid Tumor 51Solid Tumors 42Mesothelioma 41Mesothelioma, Malignant 38Hematopoietic and Lymphatic System Neoplasm 24Solid Tumor, Adult 16Ovarian Neoplasms 13Melanoma 13Malignant Solid Neoplasm 13Carcinoma, Non-Small-Cell Lung 13Sarcoma 11Pancreatic Neoplasms 11Retinoblastoma 10Colorectal Neoplasms 9Stomach Neoplasms 8Lung Neoplasms 8Advanced Malignant Solid Neoplasm 8Solid Tumours 7Small Cell Lung Carcinoma 7Cholangiocarcinoma 7Carcinoma, Renal Cell 7Advanced or Metastatic Solid Tumors 7Kidney Neoplasms 6Carcinoma, Hepatocellular 6Advanced/Metastatic Solid Tumors 6Advanced Malignant Solid Tumor 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumor Malignancies × Other solid neoplasm × 90 days × Clear all
NCT06927297 2026-03-17

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

West China Hospital

Phase 1 Recruiting
12 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 1 Not yet recruiting
42 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡